Market Overview:
The global gadolinium-based contrast media market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, neurological disorders, and cancer across the globe. In addition, rising awareness about early diagnosis and treatment of these diseases is also contributing to the growth of this market. Based on type, the global gadolinium-based contrast media market is segmented into extracellular agents, blood pool agents, and hepatobiliary agents. The extracellular agent segment is expected to account for the largest share of this market in 2018. This can be attributed to its growing use in magnetic resonance imaging (MRI) scans for detecting various types of cancers such as brain tumors and prostate cancer. Based on application, the global gadolinium-based contrast media market is divided into cardiovascular applications, neurology applications, cancer applications,, and other applications. The cardiovascular application segment accounted for the largest share of this market in 2017 owing to an increase in prevalence ratesof various heart diseases such as coronary artery disease (CAD), stroke,,and myocardial infarction (MI). However,.
Product Definition:
Gadolinium-based contrast media (GBCM) are a class of intravenous (IV) contrast agents used in medical imaging. They are used to improve the visibility of internal structures in X-rays and other types of images. GBCMs contain the element gadolinium, which gives off a bright signal when exposed to certain forms of energy such as X-rays or magnetic resonance imaging (MRI). Gadolinium is attracted to areas with high water content, such as tumors or blood vessels. When injected into the body, GBCMs help make these structures visible on images.
Extracellular Agents:
Extracellular agents are molecules that are found outside of the cells in a biological fluid such as blood or intercellular fluids. These agents can be either natural (e.g., proteins) or synthetic (e.g., gadolinium). The contrast media is used to detect and measure the amount of extracellular agent present in a patient's body during Magnetic Resonance Imaging (MRI).
Blood Pool Agents:
Blood pool agents are used in gadolinium-based contrast media to enhance the imaging of blood vessels. These agents act as local contrast mediums and help in enhancing the visibility of blood vessels during an MRI scan. The global market for Blood Pool Agents is expected to grow at a CAGR of XX% over the forecast period, owing to its increasing usage in diagnostic procedures along with an increase in investments by key players for R&D activities related to Contrast Media.
Application Insights:
The cardiovascular segment dominated the global market in terms of revenue share in 2017. Gadolinium-based contrast media is used for diagnostic and therapeutic procedures in the field of Cardiology. Increasing prevalence of cardiac diseases such as stroke, heart attack, and congenital heart disorders among all age groups boosts demand for diagnostic solutions that help detect these conditions early during diagnosis or treatment procedures.
Diagnostic applications are further classified into electrophysiology (EP) testing, angiography, catheter ablation & navigation, nuclear medicine studies (NMT), echocardiography and others. The growing adoption of advanced imaging techniques along with rising healthcare expenditure across the globe is expected to drive growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of major companies and well-established healthcare infrastructure. The region is expected to maintain its dominance over the forecast period due to increasing government funding for R&D activities, rising awareness about diagnostic techniques, and availability of skilled professionals.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare facilities & infrastructure coupled with growing medical tourism in emerging economies such as India & China. In addition, a large population base with high unmet clinical needs will support regional growth. Moreover, increasing investments by governments and private firms are also expected favorably impact industry development over the coming years.
Growth Factors:
- Increasing incidence of cardiovascular diseases and cancer
- Rising demand for minimally invasive surgeries
- Technological advancements in medical imaging procedures
- Growing awareness about the benefits of contrast media usage
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Gadolinium-based Contrast Media Market Research Report
By Type
Extracellular Agents, Blood Pool Agents, Hepatobiliary Agents
By Application
Cardiovascular, Neurology, Cancer, Others
By Companies
Bayer AG, GE Healthcare(GE), Guerbet, Lantheus Medical Imaging, Bracco Diagnostics Inc., Trivitron Healthcare, Nano Therapeutics Pvt. Ltd., Nanoscan Imaging LLC, Jodas Expoim Pvt Ltd, Magnus Health(Veracross LLC), Spago Nanomedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Gadolinium-based Contrast Media Market Report Segments:
The global Gadolinium-based Contrast Media market is segmented on the basis of:
Types
Extracellular Agents, Blood Pool Agents, Hepatobiliary Agents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Neurology, Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- GE Healthcare(GE)
- Guerbet
- Lantheus Medical Imaging
- Bracco Diagnostics Inc.
- Trivitron Healthcare
- Nano Therapeutics Pvt. Ltd.
- Nanoscan Imaging LLC
- Jodas Expoim Pvt Ltd
- Magnus Health(Veracross LLC)
- Spago Nanomedical
Highlights of The Gadolinium-based Contrast Media Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Extracellular Agents
- Blood Pool Agents
- Hepatobiliary Agents
- By Application:
- Cardiovascular
- Neurology
- Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gadolinium-based Contrast Media Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gadolinium-based contrast media is a type of imaging agent that helps doctors see structures inside the body. It is often used to help diagnose medical conditions, such as cancer.
Some of the major companies in the gadolinium-based contrast media market are Bayer AG, GE Healthcare(GE), Guerbet, Lantheus Medical Imaging, Bracco Diagnostics Inc., Trivitron Healthcare, Nano Therapeutics Pvt. Ltd., Nanoscan Imaging LLC, Jodas Expoim Pvt Ltd, Magnus Health(Veracross LLC), Spago Nanomedical.
The gadolinium-based contrast media market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gadolinium-based Contrast Media Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Gadolinium-based Contrast Media Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Gadolinium-based Contrast Media Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Gadolinium-based Contrast Media Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Gadolinium-based Contrast Media Market Size & Forecast, 2020-2028 4.5.1 Gadolinium-based Contrast Media Market Size and Y-o-Y Growth 4.5.2 Gadolinium-based Contrast Media Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Extracellular Agents
5.2.2 Blood Pool Agents
5.2.3 Hepatobiliary Agents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cardiovascular
6.2.2 Neurology
6.2.3 Cancer
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gadolinium-based Contrast Media Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gadolinium-based Contrast Media Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Extracellular Agents
9.6.2 Blood Pool Agents
9.6.3 Hepatobiliary Agents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cardiovascular
9.10.2 Neurology
9.10.3 Cancer
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Extracellular Agents
10.6.2 Blood Pool Agents
10.6.3 Hepatobiliary Agents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cardiovascular
10.10.2 Neurology
10.10.3 Cancer
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Extracellular Agents
11.6.2 Blood Pool Agents
11.6.3 Hepatobiliary Agents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cardiovascular
11.10.2 Neurology
11.10.3 Cancer
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Extracellular Agents
12.6.2 Blood Pool Agents
12.6.3 Hepatobiliary Agents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cardiovascular
12.10.2 Neurology
12.10.3 Cancer
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Extracellular Agents
13.6.2 Blood Pool Agents
13.6.3 Hepatobiliary Agents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cardiovascular
13.10.2 Neurology
13.10.3 Cancer
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gadolinium-based Contrast Media Market: Competitive Dashboard
14.2 Global Gadolinium-based Contrast Media Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer AG
14.3.2 GE Healthcare(GE)
14.3.3 Guerbet
14.3.4 Lantheus Medical Imaging
14.3.5 Bracco Diagnostics Inc.
14.3.6 Trivitron Healthcare
14.3.7 Nano Therapeutics Pvt. Ltd.
14.3.8 Nanoscan Imaging LLC
14.3.9 Jodas Expoim Pvt Ltd
14.3.10 Magnus Health(Veracross LLC)
14.3.11 Spago Nanomedical